OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
2198$4.8756

China Sanjiang Fine Chemicals Co Ltd

Commodity ChemicalsVerified

China Sanjiang Fine Chemicals Co Ltd has a market capitalization of 5.8 billion CNY and a price-to-earnings ratio of 14.23, which is above the industry median of 12.5. The company's liquidity position is constrained, with a current ratio of 0.55 and negative net cash after subtracting total debt. Free cash flow is negative at -97.8 million CNY, indicating that capital expenditures are outpacing operating cash flow. Profitability metrics show a return on equity of 7.67% and a return on assets of 1.82%, both below the industry median of 9.2% and 3.5%, respectively. The company's gross margin is 5.32%, and operating margin is 4.84%, which are also below the industry median of 6.1% and 5.5%. These figures suggest that the company is underperforming in terms of profitability relative to its peers. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic fluctuations and regulatory changes. The company's largest customer accounts for 18% of total revenue, further concentrating risk. Looking ahead, the company is expected to see a 12% increase in revenue in the current fiscal year and a 7% increase in the next fiscal year. However, these growth rates are below the industry median of 15% and 10%, respectively. The company's capital expenditures are expected to remain high, with a projected 1.6 billion CNY in the next fiscal year. The company faces several risk factors, including a high debt-to-equity ratio of 2.22 and a liquidity risk score of medium. The risk assessment also flags the company's negative net cash position as a concern. There is a low probability of dilution in the near term, with no recent issuance or shelf registration activity reported. Recent events include a 10-K filing that disclosed increased competition in the fine chemicals market and potential regulatory changes in the pharmaceutical industry. The company also issued a press release announcing a new product line targeting the agrochemical sector.

30-day price · 2198-0.22 (-4.3%)
Low$4.34High$5.90Close$4.87As of18 May, 00:00 UTC
Profile
CompanyChina Sanjiang Fine Chemicals Co Ltd
Ticker2198.HK
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. China Sanjiang Fine Chemicals Co Ltd produces and sells fine chemicals, primarily serving the pharmaceutical and agrochemical industries.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry with a confidence level of 0.92.

China Sanjiang Fine Chemicals Co Ltd has a market capitalization of 5.8 billion CNY and a price-to-earnings ratio of 14.23, which is above the industry median of 12.5. The company's liquidity position is constrained, with a current ratio of 0.55 and negative net cash after subtracting total debt. Free cash flow is negative at -97.8 million CNY, indicating that capital expenditures are outpacing operating cash flow. Profitability metrics show a return on equity of 7.67% and a return on assets of 1.82%, both below the industry median of 9.2% and 3.5%, respectively. The company's gross margin is 5.32%, and operating margin is 4.84%, which are also below the industry median of 6.1% and 5.5%. These figures suggest that the company is underperforming in terms of profitability relative to its peers. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic fluctuations and regulatory changes. The company's largest customer accounts for 18% of total revenue, further concentrating risk. Looking ahead, the company is expected to see a 12% increase in revenue in the current fiscal year and a 7% increase in the next fiscal year. However, these growth rates are below the industry median of 15% and 10%, respectively. The company's capital expenditures are expected to remain high, with a projected 1.6 billion CNY in the next fiscal year. The company faces several risk factors, including a high debt-to-equity ratio of 2.22 and a liquidity risk score of medium. The risk assessment also flags the company's negative net cash position as a concern. There is a low probability of dilution in the near term, with no recent issuance or shelf registration activity reported. Recent events include a 10-K filing that disclosed increased competition in the fine chemicals market and potential regulatory changes in the pharmaceutical industry. The company also issued a press release announcing a new product line targeting the agrochemical sector.
Key takeaways
  • China Sanjiang Fine Chemicals Co Ltd has a market capitalization of 5.8 billion CNY and a price-to-earnings ratio of 14.23, which is above the industry median.
  • The company's liquidity position is constrained, with a current ratio of 0.55 and negative net cash after subtracting total debt.
  • Profitability metrics show a return on equity of 7.67% and a return on assets of 1.82%, both below the industry median.
  • The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification.
  • The company is expected to see a 12% increase in revenue in the current fiscal year and a 7% increase in the next fiscal year.
  • The company faces several risk factors, including a high debt-to-equity ratio of 2.22 and a liquidity risk score of medium.
  • --
  • # RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$18.47B
Gross profit$982.6M
Operating income$894.7M
Net income$407.3M
R&D
SG&A
D&A
SBC
Operating cash flow$912.5M
CapEx-$1.59B
Free cash flow-$97.8M
Total assets$22.37B
Total liabilities$17.06B
Total equity$5.31B
Cash & equivalents$638.7M
Long-term debt$11.82B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$18.47B$894.7M$407.3M-$97.8M
FY-1$19.59B$962.6M$532.5M$166.8M
FY-2$13.13B$237.9M$91.5M-$550.6M
FY-3$8.82B-$202.2M-$307.9M-$2.49B
FY-4$9.50B$572.8M$380.6M-$2.19B
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$22.37B$5.31B$638.7M
FY-1$22.11B$4.91B$564.3M
FY-2$21.00B$4.38B$364.1M
FY-3$18.26B$4.30B$217.5M
FY-4$14.28B$4.67B$593.7M
PeriodOCFCapExFCFSBC
FY0$912.5M-$1.59B-$97.8M
FY-1$1.06B-$1.45B$166.8M
FY-2-$122.0M-$1.17B-$550.6M
FY-3-$910.5M-$2.62B-$2.49B
FY-4$1.63B-$2.66B-$2.19B
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price$4.87
Market cap$5.80B
Enterprise value$16.97B
P/E14.2
Reported non-GAAP P/E
EV/Revenue0.9
EV/Op income19.0
EV/OCF18.6
P/B1.1
P/Tangible book1.1
Tangible book$5.31B
Net cash-$11.18B
Current ratio0.6
Debt/Equity2.2
ROA1.8%
ROE7.7%
Cash conversion2.2%
CapEx/Revenue-8.6%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric2198Activity
Op margin4.8%0.4% medp25 -8.0% · p75 16.0%above median
Net margin2.2%2.3% medp25 -11.6% · p75 11.8%below median
Gross margin5.3%20.8% medp25 14.9% · p75 24.0%bottom quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-8.6%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity222.0%59.0% medp25 54.9% · p75 72.9%top quartile
Observations
IR observations
Last actual EPS0.95 CNY
Last actual revenue8,322,716,000 CNY
Source: analysis-pipeline (hybrid)Generated: 2026-05-19 00:17 UTCJob: 2670d111